Comparison of the effectiveness of extensor muscle strengthening exercise by itself, exercise with polydeoxyribonucleotide injection, and exercise with extracorporeal shockwave therapy in lateral epicondylitis: a randomized controlled trial

Bum Jin Shim, Eun-Min Seo, Jung-Taek Hwang, Do-Young Kim, Jae-Shin Yang, Su-Jung Seo, Myung Sun Hong, Bum Jin Shim, Eun-Min Seo, Jung-Taek Hwang, Do-Young Kim, Jae-Shin Yang, Su-Jung Seo, Myung Sun Hong

Abstract

Background: Extensor muscle strengthening exercises with counterforce braces (EX) is a conventional conservative treatment for lateral epicondylitis (LE) of the elbow. In addition, polydeoxyribonucleotide (PDRN) or extracorporeal shockwave therapy (ESWT) has been recently used for LE.

Methods: Sixty-three patients with chronic LE participated in this study and randomly allocated in three groups (G1: EX, G2: EX+PDRN injection, and G3: EX+ESWT). All of the three groups were taught to perform EX at the first out-patient department (OPD) visit. Group 2 was injected with 3 mL PDRN (5.625 mg/3 mL), while group 3 received ESWT at the first OPD visit. Visual analog scale pain score, Mayo elbow performance score (MEPS), and ultrasonographic examination were checked before, 6 weeks, and 12 weeks after the treatments.

Results: Overall functional scores and ultrasonographic findings in all three groups improved after treatment. The mean MEPS in group 2 improved more than groups 1 and 3 at 6 weeks (G1, 56.9>62.4; G2, 54.3>65.0; G3, 55.7>62.6), and more than group 1 at 12 weeks (G1, 56.9>67.9; G2, 54.3>73.6). The mean common extensor tendon depth (CETD) on ultrasonography in group 2 increased more than groups 1 and 3 at 6 and 12 weeks (6 weeks: G1, 0.385>0.386; G2, 0.332>0.392; G3, 0.334>0.357; 12 weeks: G1, 0.385>0.409; G2, 0.332>0.438; G3, 0.334>0.405 [cm]).

Conclusions: PDRN injections combined with EX exhibited a greater improvement in mean MEPS and mean CETD compared to EX only or EX combined with ESWT for LE within the 12 weeks follow-up.

Keywords: Counterforce brace; Extensor muscle strengthening exercise; Extracorporeal shockwave therapy; Lateral epicondylitis; Polydeoxyribonucleotide.

Conflict of interest statement

Conflict of interest

None.

Figures

Fig. 1.
Fig. 1.
Flow diagram of this study. EX: extensor muscle strengthening exercises with counterforce braces, US: ultrasound, PDRN: polydeoxyribonucleotide, ESWT: extracorporeal shockwave therapy.
Fig. 2.
Fig. 2.
The grading of the color Doppler activity (CDA) on longitudinal ultrasonographic examinations of the common extensor tendon origin. The grading was performed in the region of interest (ROI) defined as a 0.5 cm longitudinal part of the tendon with maximum CDA. A horizontal green line measuring 0.5 cm marks the superficial border of the ROI, white dotted lines mark the proximal and distal borders, and the bone marks the deep border. Flow towards the transducer is depicted in red while flow away from the transducer is shown in blue. (A) G0, no activity. (B) G1, single vessel in the ROI. (C) G2, CDA in 50% of the ROI. R: radial head, L: lateral epicondyle.
Fig. 3.
Fig. 3.
The common extensor tendon depth (CETD) and the common extensor tendon tear thickness (CETTT) on longitudinal ultrasonographic examinations. (A) CETD. (B) CETTT. R: radial head, J: radiohumeral joint, D: dotted line indicates tendon depth, P: plateau, L: lateral epicondyle, CETO: common extensor tendon origin, T: CETTT.
Fig. 4.
Fig. 4.
Strengthening exercise of the extensor muscle of the elbow. (A) All the fingers and wrist were fully extended, and isometric force was applied for 10 seconds. (B) A period of rest was followed for 10 seconds with all the fingers slightly flexed and the wrist neutral.
Fig. 5.
Fig. 5.
The ultrasonographic follow-up of the three groups. (A) Group 1 at initial. Color Doppler activity (CDA), grade 2; common extensor tendon depth (CETD), 4.3. (B) Group 1 at 12 weeks. CDA, grade 2; CETD, 4.4 mm. (C) Group 2 at initial. CDA, grade 2; CETD, 4.2 mm. White arrow indicates a suspicion of a partial thickness tear of the common extensor tendon. (D) Group 2 at 12 weeks. CDA, grade 1; CETD, 4.5 mm. (E) Group 3 at initial. CDA, grade 1; CETD, 3.8 mm. (F) Group 3 at 12 weeks. CDA, grade 0; CETD, 4.0 mm.

References

    1. Gündüz R, Malas FÜ, Borman P, Kocaoğlu S, Özçakar L. Physical therapy, corticosteroid injection, and extracorporeal shock wave treatment in lateral epicondylitis: clinical and ultrasonographical comparison. Clin Rheumatol. 2012;31:807–12.
    1. Krogh TP, Fredberg U, Stengaard-Pedersen K, Christensen R, Jensen P, Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med. 2013;41:625–35.
    1. Kim GM, Yoo SJ, Choi S, Park YG. Current trends for treating lateral epicondylitis. Clin Shoulder Elb. 2019;22:227–34.
    1. Lee GJ, Park D. Usefulness of polydeoxyribonucleotide as an alternative to corticosteroids in patients with lateral epicondyitis: a case series. Medicine (Baltimore) 2018;97:e10809.
    1. Altavilla D, Squadrito F, Polito F, et al. Activation of adenosine A2A receptors restores the altered cell-cycle machinery during impaired wound healing in genetically diabetic mice. Surgery. 2011;149:253–61.
    1. Galeano M, Bitto A, Altavilla D, et al. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008;16:208–17.
    1. Kwon DR, Park GY, Moon YS, Lee SC. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cells combined with polydeoxyribonucleotides on full-thickness rotator cuff tendon tear in a rabbit model. Cell Transplant. 2018;27:1613–22.
    1. Dedes V, Tzirogiannis K, Polikandrioti M, Dede AM, Mitseas A, Panoutsopoulos GI. Comparison of radial extracorporeal shockwave therapy with ultrasound therapy in patients with lateral epicondylitis. J Med Ultrason (2001) 2020;47:319–25.
    1. Nirschl RP, Kraushaar BS. Keeping tennis elbow at arm's length: simple, effective strengthening exercises. Phys Sportsmed. 1996;24:61–2.
    1. Gulabi D, Uysal MA, Akça A, Colak I, Çeçen GS, Gumustas S. USG-guided injection of corticosteroid for lateral epicondylitis does not improve clinical outcomes: a prospective randomised study. Arch Orthop Trauma Surg. 2017;137:601–6.
    1. Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand. 2004;75:93–9.
    1. Franchini M, Cruciani M, Mengoli C, et al. Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis. Blood Transfus. 2018;16:502–13.
    1. Stasinopoulos D, Johnson MI. Effectiveness of extracorporeal shock wave therapy for tennis elbow (lateral epicondylitis) Br J Sports Med. 2005;39:132–6.
    1. Haake M, König IR, Decker T, et al. Extracorporeal shock wave therapy in the treatment of lateral epicondylitis: a randomized multicenter trial. J Bone Joint Surg Am. 2002;84:1982–91.
    1. Chung B, Wiley JP. Effectiveness of extracorporeal shock wave therapy in the treatment of previously untreated lateral epicondylitis: a randomized controlled trial. Am J Sports Med. 2004;32:1660–7.
    1. Ozkut AT, Kilinçoğlu V, Ozkan NK, Eren A, Ertaş M. Extracorporeal shock wave therapy in patients with lateral epicondylitis. Acta Orthop Traumatol Turc. 2007;41:207–10.
    1. Yelland M, Rabago D, Ryan M, et al. Prolotherapy injections and physiotherapy used singly and in combination for lateral epicondylalgia: a single-blinded randomised clinical trial. BMC Musculoskelet Disord. 2019;20:509.
    1. Struijs PA, Kerkhoffs GM, Assendelft WJ, Van Dijk CN. Conservative treatment of lateral epicondylitis: brace versus physical therapy or a combination of both-a randomized clinical trial. Am J Sports Med. 2004;32:462–9.

Source: PubMed

3
Sottoscrivi